Matt focuses on Patent Litigation, serving as lead trial counsel for multinational corporations in infringement disputes, including matters involving blockbuster drugs. He also litigates trade secret cases and disputes at the intersection of intellectual property and antitrust, including those involving standard-essential patents.
